Share Email Print

Proceedings Paper

Excimer laser photorefractive keratectomy for myopia: preliminary results at one year
Author(s): Keith P. Thompson; George O. Waring; Roger Steinert; Daniel S. Durrie; Michael Gordon; Stephen F. Brint
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Excimer laser photorefractive keratectomy (PRK) is presently under investigation for the correction of myopia. Two companies in the United States, Summit Technology (Waltham, Mass.) and VisX, Inc. (Sunnyvale, Calif.) have developed excimer laser delivery systems and are participating in an FDA study to determine the safety and efficacy of PRK. This is a preliminary report on the refractive and visual results of 51 of 100 eyes treated between October 10, 1990 and March 7, 1991 by the Summit Technology UV200LA excimer laser under the FDA Phase IIB FDA protocol one year after surgery. More detailed information on eight patients treated at Emory University Eye Center (Emory Subgroup) is also reported.

Paper Details

Date Published: 14 August 1992
PDF: 11 pages
Proc. SPIE 1644, Ophthalmic Technologies II, (14 August 1992); doi: 10.1117/12.137425
Show Author Affiliations
Keith P. Thompson, Emory Univ. School of Medicine (United States)
George O. Waring, Emory Univ. School of Medicine (United States)
Roger Steinert, Emory Univ. School of Medicine (United States)
Daniel S. Durrie, Emory Univ. School of Medicine (United States)
Michael Gordon, Emory Univ. School of Medicine (United States)
Stephen F. Brint, Emory Univ. School of Medicine (United States)

Published in SPIE Proceedings Vol. 1644:
Ophthalmic Technologies II
Jean-Marie Parel, Editor(s)

© SPIE. Terms of Use
Back to Top